Results 131 to 140 of about 65,767 (202)

Multicancer early detection testing: Guidance for primary care discussions with patients

open access: yesCancer, Volume 131, Issue 7, 1 April 2025.
Abstract Multicancer early detection (MCED) tests are an emerging technology for cancer screening. MCED tests can detect cancer signals from multiple cancers concurrently in biological samples such as blood, urine, saliva, or other bodily fluids. Some tests can suggest the most likely cancer origin, whereas others report cancer detected somewhere in ...
Richard M. Hoffman   +10 more
wiley   +1 more source

Biennial Mammography Performance in the Korean National Cancer Screening Program From 2009 to 2020. [PDF]

open access: yesKorean J Radiol
Kim DJ   +8 more
europepmc   +1 more source

Rethinking Domain‐Specific Pretraining by Supervised or Self‐Supervised Learning for Chest Radiograph Classification: A Comparative Study Against ImageNet Counterparts in Cold‐Start Active Learning

open access: yesHealth Care Science, Volume 4, Issue 2, Page 110-143, April 2025.
This paper contributes a systematic analysis to examine the effectiveness of domain‐specific models against their ImageNet counterparts in cold‐start AL, proposes a representation‐based uncertainty sampling for AL initialization, and identifies key findings related to AL stages, backbone architectures, and AL paradigms. ABSTRACT Objective Deep learning
Han Yuan   +5 more
wiley   +1 more source

Diagnostic test accuracy of AI-assisted mammography for breast imaging: a narrative review. [PDF]

open access: yesPeerJ Comput Sci
Dave D   +6 more
europepmc   +1 more source

Mass Media Exposure and Cervical Cancer Screening in Rural Sub‐Saharan Africa: A Multi‐Country Cross‐Sectional Analysis

open access: yesHealth Science Reports, Volume 8, Issue 4, April 2025.
ABSTRACT Background and Aims Cervical cancer is a pressing global public health challenge, with sub‐Saharan Africa (SSA) experiencing disproportionately high incidence and mortality rates compared to other regions. Early detection through screening and timely treatment is essential for mitigating the burden of this disease.
Alex Bawuah   +4 more
wiley   +1 more source

Need for specially designed educational support groups: Young women's experiences of being identified with BRCA pathogenic variants

open access: yesJournal of Genetic Counseling, Volume 34, Issue 2, April 2025.
Abstract In Norway, genetic testing is permitted from the age of 16, and females identified with pathogenic variants in the BRCA1 or BRCA2 genes (BRCA PVs) can manage their cancer risk through screening programs and/or by undergoing risk‐reducing surgery from the age of 25 years'. This qualitative study aimed to explore and describe how women under the
Kjærsti Busk Johnsen, Nina Strømsvik
wiley   +1 more source

Home - About - Disclaimer - Privacy